Back to User profile » Dr Yanyang Liu
Papers published by Dr Yanyang Liu:
Anticancer Effects of ACT001 via NF-κB Suppression in Murine Triple-Negative Breast Cancer Cell Line 4T1
Liu Y, Wang L, Liu J, Xie X, Hu H, Luo F
Cancer Management and Research 2020, 12:5131-5139
Published Date: 26 June 2020
Anlotinib Exerts Anti-Cancer Effects on KRAS-Mutated Lung Cancer Cell Through Suppressing the MEK/ERK Pathway
Hu H, Liu Y, Tan S, Xie XX, He J, Luo F, Wang L
Cancer Management and Research 2020, 12:3579-3587
Published Date: 19 May 2020
CXCR2 is a novel cancer stem-like cell marker for triple-negative breast cancer
Wang Y, Tu L, Du C, Xie X, Liu Y, Wang J, Li Z, Jiang M, Cao D, Yan X, Luo F
OncoTargets and Therapy 2018, 11:5559-5567
Published Date: 6 September 2018
The accumulation of macrophages attenuates the effect of recombinant human endostatin on lung cancer
Liu YY, Tu L, Wang L, Long J, Wang J, Wang Y, Luo F, Cao D
OncoTargets and Therapy 2016, 9:6581-6595
Published Date: 25 October 2016